Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report
Kevin O. McNerney, Rebecca M. Richards, Paibel Aguayo‐Hiraldo, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e005957-e005957
Open Access | Times Cited: 14

Showing 14 citing articles:

Infections associated with CAR‐T cell therapy in patients with relapsed refractory multiple myeloma: Risks and prevention strategies
Jing An, Jie Zhao, Ping Zou, et al.
Cancer Medicine (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 5
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
Anne M. Spanjaart, Per Ljungman, Gloria Tridello, et al.
Leukemia (2024) Vol. 38, Iss. 9, pp. 1985-1991
Open Access | Times Cited: 4
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era
Tingting Zhang, Weiwei Tian, Shuang Wei, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy
Eleftheria Kampouri, Joshua A. Hill, M. Veronica Dioverti
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Closed Access | Times Cited: 10
Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection
Lei Tian, Taotao Qiang, Xiuding Yang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115979-115979
Closed Access | Times Cited: 10
The Efficacy of Chimeric Antigen Therapy in Viral Infectious Diseases: A Systematic Review of Randomized Controlled Trials
Hossein Hatami, Elnaz Ataei, Mohammad Javad Nasiri, et al.
Turkish Journal of Immunology (2025) Vol. 12, Iss. 3, pp. 84-91
Open Access
Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert Perspective
Paul Loubet, Iliès Benotmane, Slim Fourati, et al.
Infectious Diseases and Therapy (2025)
Open Access
INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities
Kevin O. McNerney, Emily M. Hsieh, Haneen Shalabi, et al.
Transplantation and Cellular Therapy (2023) Vol. 30, Iss. 1, pp. 38-55
Open Access | Times Cited: 9
The impact of prior COVID-19 on non-infectious endothelial complications following allogeneic hematopoietic stem cell transplantation
Chiara Oltolini, Giovanna Travi, Małgorzata Mikulska
Clinical Infectious Diseases (2024)
Closed Access | Times Cited: 2
BCMA-BBZ-OX40 CAR-T Therapy Using an Instant Manufacturing Platform in Multiple Myeloma
Ting Wang, Yazi Yang, Lie Ma, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 9, pp. e009476-e009476
Open Access | Times Cited: 1
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals
Christoph D. Spinner, Samira Bell, Hermann Einsele, et al.
Advances in Therapy (2024) Vol. 42, Iss. 2, pp. 666-719
Open Access | Times Cited: 1
When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study
Xincheng Jiang, Xiaoyan Han, Fengyan Jin, et al.
Hematology (2024) Vol. 29, Iss. 1
Open Access
Acute intestinal GVHD following donor-derived CD7-CAR-T-cell infusion in a child with Omicron COVID-19
Yu Lian, Zhilin Gao, Juanjuan Ti, et al.
Blood Science (2023) Vol. 5, Iss. 4, pp. 269-273
Open Access
[Characteristics and impact factors of SARS-CoV-2 infection in adult patients with relapsed/refractory B-cell non-Hodgkin lymphoma receiving chimeric antigen receptor T-cell therapy].
Tong Ge, Huanliang Liu, Zuming Wang, et al.
PubMed (2023) Vol. 44, Iss. 10, pp. 825-831
Closed Access
Page 1

Scroll to top